Quick Links

Contact Us

A case of erectile dysfunction and risk factors for coronary artery disease.

Authors: R A Kloner

Journal: International journal of impotence research

Publication Type: Journal Article

Date: 2005

DOI: 10.1038/sj.ijir.3901423

ID: 16391547

Affiliations:

Affiliations

    Heart Institute, Good Samaritan Hospital and Division of Cardiovascular Medicine, Keck School of Medicine at the University of Southern California, Los Angeles, 90017, USA. rkloner@goodsam.org

Abstract

The hypothetical case of a man with erectile dysfunction and multiple cardiovascular risk factors is presented to illustrate the use of the second Princeton Consensus Conference Guidelines. Methods to optimize efficacy of the phosphodiesterase inhibitors are described. The overall cardiovascular safety of the phosphodiesterase inhibitors and their interaction with organic nitrates and alpha blockers are discussed.

Chemical List

    Angiotensin-Converting Enzyme Inhibitors|||Enzyme Inhibitors|||Piperazines|||Purines|||Sulfones|||Sildenafil Citrate|||3',5'-Cyclic-GMP Phosphodiesterases